FindTrial
Sign In

Genomic Profile

PROCEDURE3 trials

Sponsors

City of Hope Medical Center, SWOG Cancer Research Network, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Conditions

Advanced Malignant Solid NeoplasmBreast CancerBreast CarcinomaColon CancerColorectal CarcinomaGenetic Risk FactorsLung CarcinomaMalignant Solid Neoplasm

Unknown Phase

HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
Active, not recruitingNCT04905082
City of Hope Medical CenterBreast Carcinoma, Colorectal Carcinoma, Lung Carcinoma +4
Start: 2021-12-30End: 2026-06-15Updated: 2026-03-24
Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment
Active, not recruitingNCT05455606
SWOG Cancer Research NetworkAdvanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm +1
Start: 2022-10-14End: 2027-03-01Updated: 2026-01-22
An Integrated Genomic Approach to Assess Genetic Risk and Drug Sensitivity
Active, not recruitingNCT07555639
Fondazione Policlinico Universitario Agostino Gemelli IRCCSBreast Cancer, Colon Cancer, Genetic Risk Factors +1
Start: 2019-11-21End: 2032-12-31Updated: 2026-04-29

Related Papers

Successful accrual of a cluster randomized controlled trial (RCT) comparing an educationally enhanced genomic tumor board (EGTB) intervention to usual practice (S2108CD, NCT# 05455606).
Journal of Clinical Oncology2025-05-28
Utilization of genomic tumor testing (GTT) among community oncologists participating in SWOG S2108CD.
JCO Oncology Practice2024-09-30
Mixed-methods analysis of physician genomic confidence in the pre-implementation phase of the cluster randomized trial evaluating genomic tumor boards (SWOG S2108CD, NCT05455606).
JCO Oncology Practice2023-10-26